IP Library › Assignment 031215/0792
Patent Assignment
Reel/Frame 031215/0792

Merger

Recorded: 2013-09-16 Pages: 103
Assignor
CGI PHARMACEUTICALS, INC.
Executed: 2010-06-23
Assignee
GILEAD CONNECTICUT, INC.
C/O GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Property (1)
N-[6-(1H-Indazol-6-Yl)Imidazo[1,2-A]Pyridin-8-Yl]-6-(Morpholin-4-Yl)Pyridazin-3-Amine, or a Pharmaceutically Acceptable Salt Thereof, as a Syk Inhibitor
Patent: 8,796,270 →
Application: 13/862,147 →
Publication: US 2013/0231330
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2013
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 031215/0767 →
Merger and Change of Name Sep 17, 2020
From: COUGAR MERGER SUB, INC.; CGI PHARMACEUTICALS, INC.; CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 053799/0190 →
Assignment of Assignor's Interest Sep 30, 2020
From: GILEAD CONNECTICUT, INC.
To: KRONOS BIO, INC.
Reel/Frame 053927/0969 →